A Study of Evacetrapib in High-Risk Vascular Disease

Clinical trial NCT01687998 · TERMINATED

Trial details

NCT number: NCT01687998
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiovascular Diseases

Start date: 2012-10-01
Primary completion: 2016-03-01
Enrollment: 12092

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.